136 related articles for article (PubMed ID: 37577790)
21. Inflammatory bowel disease in Iran: a review of 457 cases.
Aghazadeh R; Zali MR; Bahari A; Amin K; Ghahghaie F; Firouzi F
J Gastroenterol Hepatol; 2005 Nov; 20(11):1691-5. PubMed ID: 16246187
[TBL] [Abstract][Full Text] [Related]
22. Risk of uterine cervical cancer in inflammatory bowel disease: a systematic review and meta-analysis.
Kim J; Jung JH; Jo H; Kim MH; Kang DR; Kim HM
Scand J Gastroenterol; 2023; 58(12):1412-1421. PubMed ID: 37517000
[TBL] [Abstract][Full Text] [Related]
23. Increased risk of stroke among patients with inflammatory bowel disease: A PRISMA-compliant meta-analysis.
Chen Y; Wang X
Brain Behav; 2021 Jun; 11(6):e02159. PubMed ID: 33960728
[TBL] [Abstract][Full Text] [Related]
24. Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose-effect relationship.
Wijnands AM; Elias SG; Dekker E; Fidder HH; Hoentjen F; Ten Hove JR; Maljaars PWJ; van der Meulen-de Jong AE; Mooiweer E; Ouwehand RJ; Penning de Vries BBL; Ponsioen CY; van Schaik FDM; Oldenburg B;
United European Gastroenterol J; 2023 Sep; 11(7):612-620. PubMed ID: 37505117
[TBL] [Abstract][Full Text] [Related]
25. Intestinal and extraintestinal neoplasia in patients with inflammatory bowel disease in a tertiary care hospital.
Campos FG; Teixeira MG; Scanavini A; Almeida MG; Nahas SC; Cecconello I
Arq Gastroenterol; 2013 Apr; 50(2):123-9. PubMed ID: 23903622
[TBL] [Abstract][Full Text] [Related]
26. Interval Colorectal Cancer in Inflammatory Bowel Disease: A Review.
Da Cunha T; Vaziri H
J Clin Gastroenterol; 2024 Jan; 58(1):1-11. PubMed ID: 37548445
[TBL] [Abstract][Full Text] [Related]
27. Increased risk of ischemic heart disease and diabetes in inflammatory bowel disease.
Li Z; Qiao L; Yun X; Du F; Xing S; Yang M
Z Gastroenterol; 2021 Feb; 59(2):117-124. PubMed ID: 33233007
[TBL] [Abstract][Full Text] [Related]
28. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.
Rubin DT; Huo D; Kinnucan JA; Sedrak MS; McCullom NE; Bunnag AP; Raun-Royer EP; Cohen RD; Hanauer SB; Hart J; Turner JR
Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1601-8.e1-4. PubMed ID: 23872237
[TBL] [Abstract][Full Text] [Related]
29. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
30. Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis.
Singh S; Khanna S; Pardi DS; Loftus EV; Talwalkar JA
Inflamm Bowel Dis; 2013 Jul; 19(8):1631-8. PubMed ID: 23665966
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM
Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511
[TBL] [Abstract][Full Text] [Related]
32. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
[TBL] [Abstract][Full Text] [Related]
33. Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease.
Tran DH; Wang J; Ha C; Ho W; Mattai SA; Oikonomopoulos A; Weiss G; Lacey P; Cheng M; Shieh C; Mussatto CC; Ho S; Hommes D; Koon HW
BMC Gastroenterol; 2017 May; 17(1):63. PubMed ID: 28494754
[TBL] [Abstract][Full Text] [Related]
34. The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis.
Chen Y; Chen L; Xing C; Deng G; Zeng F; Xie T; Gu L; Yang H
BMC Gastroenterol; 2020 Jun; 20(1):192. PubMed ID: 32552882
[TBL] [Abstract][Full Text] [Related]
35. The Risk of Extraintestinal Cancer in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Cohort Studies.
Lo B; Zhao M; Vind I; Burisch J
Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1117-1138.e19. PubMed ID: 32801010
[TBL] [Abstract][Full Text] [Related]
36. Cancer risk in patients with inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Kliewer E; Wajda A
Cancer; 2001 Feb; 91(4):854-62. PubMed ID: 11241255
[TBL] [Abstract][Full Text] [Related]
37. Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series.
Barberio B; Savarino E; Verstockt B; Fumery M; Pugliese D; Bertani L; Buda A; Dragoni G; Goren I; Laish I; Spinelli A; Teich N; Truyens M; Ellul P
J Crohns Colitis; 2022 Dec; 16(12):1845-1852. PubMed ID: 35771951
[TBL] [Abstract][Full Text] [Related]
38. Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop.
Axelrad JE; Cross RK
Am J Gastroenterol; 2023 Mar; 118(3):429-431. PubMed ID: 36584365
[TBL] [Abstract][Full Text] [Related]
39. Nancy Index Scores of Chronic Inflammatory Bowel Disease Activity Associate With Development of Colorectal Neoplasia.
Kirchgesner J; Svrcek M; Le Gall G; Landman C; Dray X; Bourrier A; Nion-Larmurier I; Hoyeau N; Sokol H; Seksik P; Cosnes J; Fléjou JF; Beaugerie L;
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):150-157.e1. PubMed ID: 31085339
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory bowel disease and risk of breast cancer: a meta-analysis of cohort studies.
Gong C; Xu R; Zou P; Zhang Y; Wang X
Eur J Cancer Prev; 2022 Jan; 31(1):54-63. PubMed ID: 34871199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
